These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 30544746)

  • 1. Clinical Significance of Serum NEDD9 Levels in Patients with Pancreatic Cancer.
    Afsar CU; Karabulut M; Karabulut S; Ozal ST; Cikot M; Serilmez M; Tas F
    Biomolecules; 2018 Dec; 8(4):. PubMed ID: 30544746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum neural precursor cell-expressed, developmentally down regulated 9 (NEDD9) level may have a prognostic role in patients with gastric cancer.
    Karabulut M; Alis H; Afsar CU; Karabulut S; Kocatas A; Oguz H; Aykan NF
    Biomed Pharmacother; 2015 Jul; 73():140-6. PubMed ID: 26211595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Serum Interleukin-17 (IL-17) Levels as a Diagnostic Marker in Pancreatic Adenocarcinoma.
    Karabulut S; Afsar ÇU; Karabulut M; Alış H; Kılıc L; Çikot M; Yasasever CT; Aykan NF
    J Gastrointest Cancer; 2016 Mar; 47(1):47-54. PubMed ID: 26637231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating annexin A2 as a biomarker in patients with pancreatic cancer.
    Karabulut M; Afsar CU; Serilmez M; Karabulut S
    J Cancer Res Ther; 2020 Dec; 16(Supplement):S110-S115. PubMed ID: 33380663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum leptin levels may have diagnostic and predictive roles in patients with pancreatic adenocarcinoma treated with gemcitabine-based chemotherapy.
    Karabulut S; Usul Afsar C; Karabulut M; Alis H; Erturk K; Karaman S; Kones O; Bilgin E; Tas F
    J BUON; 2016; 21(4):895-902. PubMed ID: 27685911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of NEDD9 promotes cell invasion and metastasis in hepatocellular carcinoma.
    Zhou S; Xu M; Shen J; Liu X; Chen M; Cai X
    Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):677-686. PubMed ID: 28578938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical expression of NEDD9, E-cadherin and γ-catenin and their prognostic significance in pancreatic ductal adenocarcinoma (PDAC).
    Radulović P; Krušlin B
    Bosn J Basic Med Sci; 2018 Aug; 18(3):246-251. PubMed ID: 29924959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of serum interleukin-17 levels in colorectal cancer patients.
    Karabulut S; Usul Afsar C; Karabulut M; Kilic L; Alis H; Kones O; Bilgin E; Faruk Aykan N
    J BUON; 2016; 21(5):1137-1145. PubMed ID: 27837615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer.
    Han SX; Zhou X; Sui X; He CC; Cai MJ; Ma JL; Zhang YY; Zhou CY; Ma CX; Varela-Ramirez A; Zhu Q
    Oncotarget; 2015 Aug; 6(23):19907-17. PubMed ID: 26101916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of NEDD9 in hepatocellular carcinoma and its clinical significance.
    Lu P; Wang ZP; Dang Z; Zheng ZG; Li X; Zhou L; Ding R; Yue SQ; Dou KF
    Oncol Rep; 2015 May; 33(5):2375-83. PubMed ID: 25812772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of neural precursor cell-expressed developmentally down-regulated protein 9 in predicting bacillus Calmette-Guerin response in nonmuscle invasive bladder cancer.
    El-Babouly IM; Desoky EAE; El Sayed D; Ali MM; Harb OA; Ragab A; Sakr AM; Fawzi AM; Salama NM; Samaha II
    Urol Oncol; 2018 May; 36(5):242.e9-242.e14. PubMed ID: 29519561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NEDD9 overexpression is associated with the progression of and an unfavorable prognosis in epithelial ovarian cancer.
    Wang H; Mu X; Zhou S; Zhang J; Dai J; Tang L; Xiao L; Duan Z; Jia L; Chen S
    Hum Pathol; 2014 Feb; 45(2):401-8. PubMed ID: 24439227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum nectin-2 levels are diagnostic and prognostic in patients with colorectal carcinoma.
    Karabulut M; Gunaldi M; Alis H; Afsar CU; Karabulut S; Serilmez M; Akarsu C; Seyit H; Aykan NF
    Clin Transl Oncol; 2016 Feb; 18(2):160-71. PubMed ID: 26184725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of serum omentin-1 levels in patients with pancreatic adenocarcinoma.
    Karabulut S; Afsar CU; Karabulut M; Alis H; Bozkurt MA; Aydogan F; Serilmez M; Tas F
    BBA Clin; 2016 Dec; 6():138-142. PubMed ID: 27785418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of serum M30 and M65 levels in metastatic pancreatic adenocarcinoma.
    Tas F; Karabulut S; Bilgin E; Sen F; Yildiz I; Tastekin D; Ciftci R; Duranyildiz D
    Tumour Biol; 2013 Dec; 34(6):3529-36. PubMed ID: 23784459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of serum neural precursor cell-expressed developmentally downregulated protein 9 in melanoma.
    Erturk K; Tas F; Serilmez M; Bilgin E; Duranyildiz D
    Mol Clin Oncol; 2018 Jan; 8(1):204-208. PubMed ID: 29387415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between S100A4 protein expression and pre-operative serum CA19.9 levels in pancreatic carcinoma and its prognostic significance.
    Jia F; Liu M; Li X; Zhang F; Yue S; Liu J
    World J Surg Oncol; 2019 Sep; 17(1):163. PubMed ID: 31526392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing novel prognostic serum biomarkers in advanced pancreatic cancer: the role of CYFRA 21-1, serum amyloid A, haptoglobin, and 25-OH vitamin D3.
    Haas M; Kern C; Kruger S; Michl M; Modest DP; Giessen C; Schulz C; von Einem JC; Ormanns S; Laubender RP; Holdenrieder S; Heinemann V; Boeck S
    Tumour Biol; 2015 Apr; 36(4):2631-40. PubMed ID: 25472579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating nucleosomes and immunogenic cell death markers HMGB1, sRAGE and DNAse in patients with advanced pancreatic cancer undergoing chemotherapy.
    Wittwer C; Boeck S; Heinemann V; Haas M; Stieber P; Nagel D; Holdenrieder S
    Int J Cancer; 2013 Dec; 133(11):2619-30. PubMed ID: 23729200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum miR-629 is a novel molecular marker for diagnosis and the prognosis of pancreatic cancer.
    Shi W; Lu Y; Gong R; Sun JJ; Liu G
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(16):5187-5193. PubMed ID: 30178840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.